CAR-T Therapy for Acute Lymphoblastic Leukemia (ALL) at Sheba Medical Center

• Terapi sel T CAR
• Perawatan pasca-operasi
• 3 kali makan per hari oleh ahli gizi
• layanan perawat 24 jam
• CT Scan
• Elektrokardiogram (EKG)
• Konsultasi dengan dokter
• Tes prabedah
• Tes darah
• Pemeriksaan tindak lanjut
• Tes darah biokimia
• PET/CT
• Konsultasi dengan ahli onkologi
• Konsultasi dengan ahli hematologi
• Konsultasi dengan ahli imunologi
• Konsultasi dengan dokter hematologi pediatrik
• Konsultasi dengan onkohematologis
• Biopsi
• Hitung darah lengkap dengan penanda kanker dan proteinogram
• CT angiografi

• 21 hari di rumah sakit

• Transfer bandara-klinik-bandara

CAR-T Therapy for Acute Lymphoblastic Leukemia (ALL) at Sheba Medical Center

For patients diagnosed with Acute Lymphoblastic Leukemia (ALL), especially those with relapsed or treatment-resistant disease, access to advanced therapy can be life-changing.
Sheba Medical Center, ranked among the World's Top 10 Hospitals by Newsweek 2026, offers state-of-the-art CAR-T cell therapy, providing new hope where conventional treatments may no longer be effective.
Sheba Medical Center is internationally recognized for its expertise in advanced cellular therapies, including CAR-T therapy for ALL, particularly in pediatric and young adult patients, combining cutting-edge science with extensive clinical experience.

A Faster Path to Life-Saving Treatment

At Sheba, the entire CAR-T process is performed on-site, ensuring speed, precision, and optimal cell quality, critical in fast-progressing diseases like ALL.

• Apheresis – collection of the patient’s T-cells
• Cell Engineering – genetic modification at Sheba’s Advanced Biotherapy Center
• Infusion – reinfusion of modified cells designed to target and eliminate leukemia cells

By keeping the entire process in-house, treatment can begin in approximately 10 days, significantly faster than many international centers.
CAR-T therapy acts as a “living drug,” continuing to work in the body and offering the potential for deep and lasting remission.
All patients are treated under the leadership of Prof. Arnon Nagler, a globally recognized expert in hemato-oncology.

Outstanding Outcomes That Offer Real Hope

These outcomes provide a powerful treatment option and a second chance for patients with limited alternatives.

Why Patients Choose Sheba

• Rapid access to CAR-T therapy – treatment initiation in ~10 days
• Extensive experience – leading CAR-T program in the region
• Dedicated CAR-T units – specialized care with 24/7 monitoring
• Multidisciplinary expertise – hematology, oncology, and immunotherapy teams working together
• Full international support – medical review, travel coordination, and patient assistance

Comprehensive, Personalized Care

Each patient undergoes a full diagnostic evaluation, including advanced imaging, bone marrow biopsy, genetic and molecular testing, and complete medical assessment, ensuring a precise, individualized treatment plan.
Services are available in English, Russian, and Arabic, providing a seamless experience for international patients and their families.

By combining innovative CAR-T technology, in-house cell production, and world-class expertise, Sheba delivers one of the most advanced and accessible CAR-T programs for ALL worldwide, offering patients not just treatment, but a real opportunity for remission and renewed life.

• Koordinator medis pribadi
• Pengaturan perjalanan medis — pemesanan tiket pesawat dan kamar hotel dengan harga mitra khusus
• Pendampingan pasien selama perjalanan medis